Strides Pharma Science has attached Press Release issued by the Company titled: ‘Strides receives USFDA approval for Acetaminophen and Ibuprofen Tablets, 125 mg /250 mg, Expanding the Existing OTC Portfolio’.
The above information is a part of company’s filings submitted to BSE.